{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:46:44Z","timestamp":1794336404501,"version":"4.9.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160371"],"award-info":[{"award-number":["82160371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100869"],"award-info":[{"award-number":["82100869"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation in Jiangxi Province grant","award":["20224ACB216009"],"award-info":[{"award-number":["20224ACB216009"]}]},{"name":"Jiangxi Province Thousands of Plans","award":["jxsq2023201105"],"award-info":[{"award-number":["jxsq2023201105"]}]},{"name":"Hengrui Diabetes Metabolism Research Fund","award":["Z-2017-26-2202-4"],"award-info":[{"award-number":["Z-2017-26-2202-4"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong","doi-asserted-by":"crossref","award":["202201011395"],"award-info":[{"award-number":["202201011395"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Basic and Applied Basic Research Project of Guangzhou","award":["202201011395"],"award-info":[{"award-number":["202201011395"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The triglyceride-glucose (TyG) index is recognized as an alternative measure of insulin resistance (IR) and has been linked to the risks of cardiovascular disease (CVD) and mortality. This study aimed to evaluate whether the association between the TyG index and CVD mortality is influenced by the use of antidiabetic and hypolipidemic agents, given their potential modifying effects on the TyG index.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Participants from the National Health and Nutrition Examination Survey (1999\u20132018) were included in the study. Mortality outcomes were tracked through linkage with National Death Index records until December 31, 2019. Data on the use of antidiabetic and hypolipidemic medications (including prescribed insulin, diabetic pills, and cholesterol-lowering agents) were self-reported by participants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 5,046 adults (representing 42,753,806 individuals, weighted mean age 61.08 years [SE: 0.24]; 49.35% female) were analyzed. The TyG index was significantly associated with all-cause and CVD mortality, and these associations were modified by the use of antidiabetic and hypolipidemic agents (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Significant interactions were observed between the TyG index and the use of these agents for mortality outcomes after full adjustments (p-value for interaction\u2009&lt;\u20090.05). Exposure-effect analysis revealed a U-shaped relationship between TyG index levels and the risks of all-cause and CVD mortality in participants using these agents, while a linear positive relationship was observed in participants not using these agents.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The use of antidiabetic and hypolipidemic agents modify the association between the TyG index and all-cause and CVD mortality. These findings suggest that future studies on the TyG index and its relationship with CVD and mortality should account for the modifying effects of these agents.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s12933-025-02620-z","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T13:52:15Z","timestamp":1738936335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The association between TyG index and cardiovascular mortality is modified by antidiabetic or lipid-lowering agent: a prospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Changchang","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanqin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"2","key":"2620_CR1","first-page":"713","volume":"86","author":"SI McFarlane","year":"2001","unstructured":"McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metabolism. 2001;86(2):713\u20138.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"2620_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.diabet.2011.01.002","volume":"37","author":"B Antuna-Puente","year":"2011","unstructured":"Antuna-Puente B, Disse E, Rabasa-Lhoret R, Laville M, Capeau J, Bastard J-P. How can we measure insulin sensitivity\/resistance? Diabetes Metab. 2011;37(3):179\u201388.","journal-title":"Diabetes Metab"},{"issue":"4","key":"2620_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"7","key":"2620_CR4","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metabolism. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"2620_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-023-01819-2","volume":"22","author":"F Liu","year":"2023","unstructured":"Liu F, Ling Q, Xie S, Xu Y, Liu M, Hu Q, et al. Association between triglyceride glucose index and arterial stiffness and coronary artery calcification: a systematic review and exposure-effect meta-analysis. Cardiovasc Diabetol. 2023;22(1):111.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-022-01688-1","volume":"22","author":"X Liu","year":"2023","unstructured":"Liu X, Abudukeremu A, Jiang Y, Cao Z, Wu M, Ma J, et al. U-shaped association between the triglyceride\u2013glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease. Cardiovasc Diabetol. 2023;22(1):1\u201312.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):1\u201317.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12933-023-02055-4","volume":"22","author":"C Cui","year":"2023","unstructured":"Cui C, Liu L, Zhang T, Fang L, Mo Z, Qi Y, et al. Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2023;22(1):325.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12933-023-01918-0","volume":"22","author":"Y Boshen","year":"2023","unstructured":"Boshen Y, Yuankang Z, Xinjie Z, Taixi L, Kaifan N, Zhixiang W, et al. Triglyceride-glucose index is associated with the occurrence and prognosis of cardiac arrest: a multicenter retrospective observational study. Cardiovasc Diabetol. 2023;22(1):190.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12933-023-01973-7","volume":"22","author":"A Khalaji","year":"2023","unstructured":"Khalaji A, Behnoush AH, Khanmohammadi S, Ghanbari Mardasi K, Sharifkashani S, Sahebkar A, et al. Triglyceride-glucose index and heart failure: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):244.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-023-02013-0","volume":"23","author":"Z Xu","year":"2024","unstructured":"Xu Z, Chen P, Wang L, Yan J, Yan X, Li D. Relationship between TyG index and the degree of coronary artery lesions in patients with H-type hypertension. Cardiovasc Diabetol. 2024;23(1):23.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12933-023-02001-4","volume":"22","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Yang J, Tang H, Guo Z, Dong W, Wang Y, et al. High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction. Cardiovasc Diabetol. 2023;22(1):263.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-019-0982-2","volume":"19","author":"J Alizargar","year":"2020","unstructured":"Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol. 2020;19(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"2620_CR17","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.numecd.2022.07.024","volume":"32","author":"SA Nabipoorashrafi","year":"2022","unstructured":"Nabipoorashrafi SA, Seyedi SA, Rabizadeh S, Ebrahimi M, Ranjbar SA, Reyhan SK, et al. The accuracy of triglyceride-glucose (TyG) index for the screening of metabolic syndrome in adults: a systematic review and meta-analysis. Nutr Metabolism Cardiovasc Dis. 2022;32(12):2677\u201388.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"2620_CR18","doi-asserted-by":"publisher","first-page":"774567","DOI":"10.3389\/fendo.2021.774567","volume":"12","author":"Z Qin","year":"2021","unstructured":"Qin Z, Zhao J, Geng J, Chang K, Liao R, Su B. Higher triglyceride\u2013glucose index is associated with increased likelihood of kidney stones. Front Endocrinol. 2021;12:774567.","journal-title":"Front Endocrinol"},{"issue":"4","key":"2620_CR19","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1212\/WNL.0000000000201467","volume":"100","author":"R Zhang","year":"2023","unstructured":"Zhang R, Liu H, Pu L, Zhao T, Zhang S, Han K, et al. Global burden of ischemic stroke in young adults in 204 countries and territories. Neurology. 2023;100(4):e422\u201334.","journal-title":"Neurology"},{"key":"2620_CR20","unstructured":"Organization WH. International Statistical classification of diseases and related health problems: alphabetical index. World Health Organization; 2004."},{"key":"2620_CR21","unstructured":"Canada Go. Tobacco Use Statistics 2008 [Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/health-concerns\/tobacco\/research\/tobacco-use-statistics\/terminology.html"},{"key":"2620_CR22","first-page":"741","volume-title":"Encyclopedia of behavioral medicine","author":"MD McNutt","year":"2013","unstructured":"McNutt MD, Webb Hooper M. Ex-smokers. In: Gellman MD, Turner JR, editors. Encyclopedia of behavioral medicine. New York, NY: Springer New York; 2013. pp. 741\u20132."},{"key":"2620_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11113-013-9268-7","volume":"32","author":"RG Rogers","year":"2013","unstructured":"Rogers RG, Krueger PM, Miech R, Lawrence EM, Kemp R. Nondrinker mortality risk in the United States. Popul Res Policy Rev. 2013;32:325\u201352.","journal-title":"Popul Res Policy Rev"},{"issue":"1","key":"2620_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/10826084.2021.1990331","volume":"57","author":"A Katainen","year":"2022","unstructured":"Katainen A, H\u00e4rk\u00f6nen J, M\u00e4kel\u00e4 P. Non-drinkers\u2019 experiences of drinking occasions: a population-based study of social consequences of abstaining from alcohol. Subst Use Misuse. 2022;57(1):57\u201366.","journal-title":"Subst Use Misuse"},{"key":"2620_CR25","unstructured":"World Health Organization Global Physical Activity Questionnaire (GPAQ). Analysis Guide. [Available from: https:\/\/www.who.int\/ncds\/surveillance\/steps\/resources\/GPAQ_Analysis_Guide.pdf"},{"key":"2620_CR26","unstructured":"The U.S. Department of Health. and Human Services Physical Activity Guidelines for Americans. [Available from: https:\/\/health.gov\/paguidelines\/guidelines\/chapter5.aspx"},{"key":"2620_CR27","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):2199-269.","DOI":"10.1161\/HYP.0000000000000075"},{"key":"2620_CR28","doi-asserted-by":"crossref","unstructured":"Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, et al. American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr Pract. 2015;21 Suppl 1(Suppl 1):1-87.","DOI":"10.4158\/EP15672.GLSUPPL"},{"key":"2620_CR29","doi-asserted-by":"crossref","unstructured":"Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. Jama. 2015;314(10):1021-9.","DOI":"10.1001\/jama.2015.10029"},{"issue":"25","key":"2620_CR30","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP)","year":"2002","unstructured":"Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143\u2013421.","journal-title":"Circulation"},{"key":"2620_CR31","doi-asserted-by":"crossref","unstructured":"Marston NA, Pirruccello JP, Melloni GEM, Koyama S, Kamanu FK, Weng LC, et al. Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention. JAMA Cardiol. 2023;8(2):130-7.","DOI":"10.1001\/jamacardio.2022.4466"},{"key":"2620_CR32","doi-asserted-by":"crossref","unstructured":"Patel KK, McGhie AI, Kennedy KF, Thompson RC, Spertus JA, Sperry BW, et al. Impact of Positron Emission Tomographic Myocardial Perfusion Imaging on Patient Selection for Revascularization. J Am Coll Cardiol. 2023;82(17):1662-72","DOI":"10.1016\/j.jacc.2023.08.027"},{"key":"2620_CR33","unstructured":"Statistics NCfH. The national health and nutrition examination survey (nhanes) analytic and reporting guidelines. URL http:\/\/www cdc.gov\/nchs\/data\/nhanes\/nhanes_03_04\/nhanes_ analytic_guidelines_dec_2005 pdf (accessed December 20, 2011). 2011."},{"issue":"1","key":"2620_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12933-023-01906-4","volume":"22","author":"S Liang","year":"2023","unstructured":"Liang S, Wang C, Zhang J, Liu Z, Bai Y, Chen Z, et al. Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis. Cardiovasc Diabetol. 2023;22(1):170.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12933-023-01864-x","volume":"22","author":"W Cai","year":"2023","unstructured":"Cai W, Xu J, Wu X, Chen Z, Zeng L, Song X, et al. Association between triglyceride-glucose index and all-cause mortality in critically ill patients with ischemic stroke: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22(1):138.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13098-023-01153-3","volume":"15","author":"H Li","year":"2023","unstructured":"Li H, Jiang Y, Su X, Meng Z. The triglyceride glucose index was U-shape associated with all-cause mortality in population with cardiovascular diseases. Diabetol Metab Syndr. 2023;15(1):181.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2620_CR37","doi-asserted-by":"publisher","first-page":"16478","DOI":"10.1038\/s41598-023-43512-0","volume":"13","author":"M Zhao","year":"2023","unstructured":"Zhao M, Xiao M, Tan Q, Lu F. Triglyceride glucose index as a predictor of mortality in middle-aged and elderly patients with type 2 diabetes in the US. Sci Rep. 2023;13(1):16478.","journal-title":"Sci Rep"},{"issue":"1","key":"2620_CR38","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12933-023-02054-5","volume":"22","author":"J Chen","year":"2023","unstructured":"Chen J, Wu K, Lin Y, Huang M, Xie S. Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Cardiovasc Diabetol. 2023;22(1):320.","journal-title":"Cardiovasc Diabetol"},{"key":"2620_CR39","doi-asserted-by":"crossref","unstructured":"Liu Q, Cui H, Ma Y, Han X, Cao Z, Wu Y. Triglyceride-glucose index associated with the risk of cardiovascular disease: the Kailuan study. Endocrine. 2022:1\u20138.","DOI":"10.21203\/rs.3.rs-634725\/v1"},{"issue":"1","key":"2620_CR40","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/j.jacl.2023.11.006","volume":"18","author":"H-M Park","year":"2024","unstructured":"Park H-M, Han T, Heo S-J, Kwon Y-J. Effectiveness of the triglyceride-glucose index and triglyceride-glucose-related indices in predicting cardiovascular disease in middle-aged and older adults: a prospective cohort study. J Clin Lipidol. 2024;18(1):e70\u20139.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"2620_CR41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12933-024-02275-2","volume":"23","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liu W, Xu B, Wang S, Du Z, Cheng W. Association of triglyceride glucose index and triglyceride glucose-body mass index with sudden cardiac arrest in the general population. Cardiovasc Diabetol. 2024;23(1):173.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-022-01593-7","volume":"21","author":"X Xu","year":"2022","unstructured":"Xu X, Huang R, Lin Y, Guo Y, Xiong Z, Zhong X, et al. High triglyceride-glucose index in young adulthood is associated with incident cardiovascular disease and mortality in later life: insight from the CARDIA study. Cardiovasc Diabetol. 2022;21(1):155.","journal-title":"Cardiovasc Diabetol"},{"key":"2620_CR43","doi-asserted-by":"crossref","unstructured":"He G, Zhang Z, Wang C, Wang W, Bai X, He L et al. Association of the triglyceride\u2013glucose index with all-cause and cause-specific mortality: a population-based cohort study of 3.5 million adults in China. Lancet Reg Health\u2013Western Pac. 2024;49.","DOI":"10.1016\/j.lanwpc.2024.101135"},{"issue":"1","key":"2620_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12933-024-02269-0","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C, Liang D, Xiao K, Xie L. Association between the triglyceride\u2013glucose index and all-cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024;23(1):171.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12933-022-01694-3","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu L, Wu Z, Zhuang Y, Zhang Y, Cui H, Lu F, et al. Association of triglyceride\u2013glucose index and traditional risk factors with cardiovascular disease among non-diabetic population: a 10-year prospective cohort study. Cardiovasc Diabetol. 2022;21(1):256.","journal-title":"Cardiovasc Diabetol"},{"key":"2620_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-020-01186-2","volume":"19","author":"B Park","year":"2020","unstructured":"Park B, Lee Y-J, Lee HS, Jung D-H. The triglyceride-glucose index predicts ischemic heart disease risk in koreans: a prospective study using National Health Insurance Service data. Cardiovasc Diabetol. 2020;19:1\u20138.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2620_CR47","doi-asserted-by":"publisher","first-page":"178","DOI":"10.12997\/jla.2022.11.2.178","volume":"11","author":"YK Cho","year":"2022","unstructured":"Cho YK, Kim HS, Jung CH, Park J-Y, Lee WJ. Triglyceride-glucose index is a useful marker for predicting future cardiovascular disease and mortality in young Korean adults: a nationwide population-based cohort study. J Lipid Atherosclerosis. 2022;11(2):178.","journal-title":"J Lipid Atherosclerosis"},{"key":"2620_CR48","first-page":"101135","volume":"49","author":"G He","year":"2024","unstructured":"He G, Zhang Z, Wang C, Wang W, Bai X, He L, et al. Association of the triglyceride-glucose index with all-cause and cause-specific mortality: a population-based cohort study of 3.5 million adults in China. Lancet Reg Health West Pac. 2024;49:101135.","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"2620_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12933-024-02120-6","volume":"23","author":"Y Yao","year":"2024","unstructured":"Yao Y, Wang B, Geng T, Chen J, Chen W, Li L. The association between TyG and all-cause\/non-cardiovascular mortality in general patients with type 2 diabetes mellitus is modified by age: results from the cohort study of NHANES 1999\u20132018. Cardiovasc Diabetol. 2024;23(1):43.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2620_CR50","first-page":"4678526","volume":"2020","author":"A S\u00e1nchez-Garc\u00eda","year":"2020","unstructured":"S\u00e1nchez-Garc\u00eda A, Rodr\u00edguez-Guti\u00e9rrez R, Mancillas-Adame L, Gonz\u00e1lez-Nava V, D\u00edaz Gonz\u00e1lez-Colmenero A, Solis RC, et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol. 2020;2020(1):4678526.","journal-title":"Int J Endocrinol"},{"issue":"3","key":"2620_CR51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/aps.2010.17","volume":"31","author":"X Chen","year":"2010","unstructured":"Chen X, Yu QQ, Zhu YH, Bi Y, Sun WP, Liang H, et al. Insulin therapy stimulates lipid synthesis and improves endocrine functions of adipocytes in dietary obese C57BL\/6 mice. Acta Pharmacol Sin. 2010;31(3):341\u20136.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"2620_CR52","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1042\/cs0990351","volume":"99","author":"P Galassetti","year":"2000","unstructured":"Galassetti P, Davis SN. Effects of insulin per se on neuroendocrine and metabolic counter-regulatory responses to hypoglycaemia. Clin Sci (Lond). 2000;99(5):351\u201362.","journal-title":"Clin Sci (Lond)"},{"issue":"19","key":"2620_CR53","doi-asserted-by":"publisher","first-page":"e2286","DOI":"10.1212\/WNL.0000000000007454","volume":"92","author":"PM Rist","year":"2019","unstructured":"Rist PM, Buring JE, Ridker PM, Kase CS, Kurth T, Rexrode KM. Lipid levels and the risk of hemorrhagic stroke among women. Neurology. 2019;92(19):e2286\u201394.","journal-title":"Neurology"},{"issue":"5","key":"2620_CR54","first-page":"521","volume":"40","author":"G Kozdag","year":"2013","unstructured":"Kozdag G, Ertas G, Emre E, Akay Y, Celikyurt U, Sahin T, et al. Low serum triglyceride levels as predictors of cardiac death in heart failure patients. Tex Heart Inst J. 2013;40(5):521\u20138.","journal-title":"Tex Heart Inst J"},{"issue":"1","key":"2620_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-020-01054-z","volume":"19","author":"L Wang","year":"2020","unstructured":"Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80.","journal-title":"Cardiovasc Diabetol"},{"key":"2620_CR56","first-page":"200250","volume":"20","author":"K Otsuka","year":"2024","unstructured":"Otsuka K, Yamaura H, Shimada K, Sugiyama T, Hojo K, Ishikawa H, et al. Impact of diabetes mellitus and triglyceride glucose index on mortality and cardiovascular outcomes in patients with chronic coronary syndrome undergoing coronary computed tomography angiography. Int J Cardiol Cardiovasc Risk Prev. 2024;20:200250.","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"2620_CR57","doi-asserted-by":"publisher","first-page":"778038","DOI":"10.3389\/fcvm.2021.778038","volume":"8","author":"D Zhou","year":"2021","unstructured":"Zhou D, Liu XC, Kenneth L, Huang YQ, Feng YQ. A non-linear association of triglyceride glycemic index with cardiovascular and all-cause mortality among patients with hypertension. Front Cardiovasc Med. 2021;8:778038.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2620_CR58","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12944-023-01981-2","volume":"22","author":"A Kityo","year":"2023","unstructured":"Kityo A, Lee SA. Association of cardiometabolic factors and insulin resistance surrogates with mortality in participants from the Korean Genome and Epidemiology Study. Lipids Health Dis. 2023;22(1):210.","journal-title":"Lipids Health Dis"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02620-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02620-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02620-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T13:52:37Z","timestamp":1738936357000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02620-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2620"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02620-z","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the NHANES Institutional Review Board and implemented in accordance with the Declaration of Helsinki, with all NHANES participants providing signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no relevant conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}